Assignee
ERIMOS PHARMACEUTICALS LLC
US·2 granted patents·5 pending applications·10 citations·filing 2005–2022
Top patents by PatentIndex Score
7 records- 0180US7728036B2Methods for delivery of catecholic butanes for treatment of tumorsERIMOS PHARMACEUTICALS LLC·Filed 2005·Granted Jun 1, 2010·10 cites·95 claims
- 0255US11844768B2Terameprocol and nordihydroguaiaretic acid (NDGA) derivatives as coronavirus anti-viral agentsERIMOS PHARMACEUTICALS LLC·Filed 2022·Granted Dec 19, 2023·0 cites·22 claims
- 0345US2009022803A1Oral Formulations For Delivery of Catecholic Butanes Including Ndga CompoundsERIMOS PHARMACEUTICALS LLC·Filed 2006·Application pending·0 cites
- 0445US2008096967A1Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into AnimalsERIMOS PHARMACEUTICALS LLC·Filed 2006·Application pending·0 cites
- 0543US2010093872A1Stable aqueous formulations of water insoluble or poorly soluble drugsERIMOS PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 0643US2006141029A1Methods and compositions for delivery of catecholic butanes for treatment of diseasesERIMOS PHARMACEUTICALS LLC·Filed 2005·Application pending·0 cites
- 0737US2015374709A1Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical useERIMOS PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →